Most discussions around GLP-based peptides
Mechanistically, GLP-1 receptor activation influences multiple pathways: Delayed gastric emptying → slower nutrient absorption Central signaling → satiety + reduced food drive Insulin secretion → improved glycemic control Glucagon suppression → reduced hepatic glucose output What’s interesting is that appetite reduction is often the first noticeable effect,but metabolic adaptations may take longer to fully express. This raises a question: Are most people evaluating results too early based only on appetite changes? Or overlooking metabolic improvements that aren’t immediately visible?